Vident Investment Advisory’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-18,142	Closed	-$2.25M	–	528
2023 Q2	$2.25M	Sell	18,142 -50,653	-74%	-$6.82M	0.08%	285
2023 Q1	$10.1M	Buy	68,795 +48,595	+241%	+$7.19M	0.33%	70
2022 Q4	$3.22M	Sell	20,200 -1,114	-5%	-$163K	0.12%	197
2022 Q3	$2.8M	Sell	21,314 -5,721	-21%	-$870K	0.09%	248
2022 Q2	$4.21M	Sell	27,035 -16,166	-37%	-$2.49M	0.13%	196
2022 Q1	$6.72M	Sell	43,201 -15,729	-27%	-$2.28M	0.18%	136
2021 Q4	$7.51M	Sell	58,930 -12,579	-18%	-$1.65M	0.2%	111
2021 Q3	$9.31M	Buy	71,509 +56,013	+361%	+$8.46M	0.28%	71
2021 Q2	$2.75M	Sell	15,496 -704	-4%	-$122K	0.08%	272
2021 Q1	$2.66M	Sell	16,200 -1,592	-9%	-$262K	0.09%	247
2020 Q4	$2.94M	Sell	17,792 -1,259	-7%	-$188K	0.12%	146
2020 Q3	$2.72M	Sell	19,051 -2,204	-10%	-$273K	0.14%	135
2020 Q2	$2.35M	Sell	21,255 -5,949	-22%	-$658K	0.12%	159
2020 Q1	$2.71M	Buy	27,204 +22,874	+528%	+$2.96M	0.18%	112
2019 Q4	$646K	Sell	4,330 -132	-3%	-$18K	0.04%	484
2019 Q3	$572K	Sell	4,462 -10	-0.2%	-$1.34K	0.05%	294
2019 Q2	$638K	Sell	4,472 -2,774	-38%	-$373K	0.05%	253
2019 Q1	$1.04M	Buy	7,246 +2,773	+62%	+$362K	0.06%	411
2018 Q4	$554K	Buy	+4,473	New	+$664K	0.03%	557
2018 Q1	–	Sell	-24,636	Closed	-$3.32M	–	923
2017 Q4	$3.32M	Buy	24,636 +1,320	+6%	+$183K	0.15%	159
2017 Q3	$3.41M	Buy	23,316 +21,477	+1,168%	+$3.25M	0.18%	101
2017 Q2	$286K	Sell	1,839 -401	-18%	-$61.3K	0.02%	397
2017 Q1	$325K	Buy	+2,240	New	+$292K	0.03%	362
2015 Q4	–	Sell	-9,775	Closed	-$1.3M	–	613
2015 Q3	$1.3M	Buy	9,775 +3,246	+50%	+$559K	0.18%	142
2015 Q2	$1.15M	Buy	+6,529	New	+$1.17M	0.15%	181